相关实验视频

Updated: Jan 17, 2026

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

在肝移植后患有早期肝功能障碍的患者中使用simodeacoction

Weihang Zhong¹, Haijin Lyu¹, Yuping Li¹

¹Organ Transplantation Intensive Care Unit, Sun Yat-sen University Third Affiliated Hospital, Tianhe Road, Tianhe District, Guangzhou City, Guangdong, China.

Pakistan journal of pharmaceutical sciences

|September 25, 2025

概括

在肝移植患者中,西莫改善了胃肠功能,降低了血液氨量. 这种传统的草药有助于恢复,而不会影响肝脏或脏功能.

科学领域:

肝病学肝病学是一种肝病学.
移植医学移植医学
综合医学是一个整体的医学.

背景情况:

肝移植 (LT) 患者经常经历早期肝功能障碍和胃肠道问题.
优化移植后恢复和管理并发症对于患者的治疗结果至关重要.

研究的目的:

评估Simo在管理LT后早期肝功能障碍方面的疗效.
评估其对胃肠功能,肝功能和代谢参数的影响.

主要方法:

一项随机对照试验,涉及138名接受LT治疗的患者.
患者接受了标准护理加安慰剂 (对照组) 或标准护理加西莫 (实验组).
关键参数包括肝酶,血氨,胃残留体积和排便时间从术后1-5天被监测.

主要成果:

西莫脱组的血液氨水平显著降低,排便时间更早.
实验组的肠道营养摄入量在后期的术后几天更高.
肝功能标志物 (ALT,AST, bilirubin) 呈现下降趋势,而功能标志物保持稳定.

结论:

在肝移植后,Simo 蒸在改善胃肠功能和代谢参数方面表现出有益的作用.
它有助于消除毒素,并促进胃肠道的恢复,而不会对肝脏或功能产生不良影响.
这表明Simo作为肝移植后患者的潜在辅助疗法.

更多相关视频

Author Spotlight: Advancements and Challenges in Machine Perfusion for Liver Transplantation

Author Spotlight: Advancements and Challenges in Machine Perfusion for Liver Transplantation

Published on: June 14, 2024

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...